Company / Cash per Share
NeoGenomics Laboratories, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.25
FY2025
5-year range
$1.25 / $2.90
FY2021-FY2025
Trend
-57.0%
vs FY2024
Sector context
#110 of 146
Health Care
What the data says
NeoGenomics Laboratories, Inc.'s cash per share of $1.25 is lower than 75% of companies in the Health Care sector (FY2025). Cash per Share has fluctuated over the past 10 years, ranging from $0.11 in FY2018 to $2.90 in FY2024.
Based on SEC 10-K filings.
1.25 in FY2025 with a 5-year CAGR of -9.4%.
Declined from $2.73 to $1.25 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -16.2%
- 5-Year CAGR
- -9.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 146This company $1.25 Sector average $27.70
▼
-95.5% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 57.0% year-over-year.
- Ranks #110 out of 146 companies in the Health Care sector.
- Peak cash per share was recorded in FY2024.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.25 | -57.0% |
| FY2024 | $2.90 | +6.2% |
| FY2023 | $2.73 | +28.8% |
| FY2022 | $2.12 | -19.8% |
| FY2021 | $2.64 | +29.1% |
| FY2020 | $2.05 | +22.5% |
| FY2019 | $1.67 | +1458.5% |
| FY2018 | $0.11 | -34.3% |
| FY2017 | $0.16 | -1.2% |
| FY2016 | $0.17 | -57.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026